Alzamend Neuro
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alzamend Neuro and other ETFs, options, and stocks.About ALZN
Alzamend Neuro, Inc. is an early clinical-stage biopharmaceutical company, which focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease.
CEOStephan Jackman
CEOStephan Jackman
Employees4
Employees4
HeadquartersAtlanta, Georgia
HeadquartersAtlanta, Georgia
Founded2016
Founded2016
Employees4
Employees4
ALZN Key Statistics
Market cap4.94M
Market cap4.94M
Price-Earnings ratio-0.38
Price-Earnings ratio-0.38
Dividend yield—
Dividend yield—
Average volume26.27K
Average volume26.27K
High today$0.77
High today$0.77
Low today$0.6699
Low today$0.6699
Open price$0.7651
Open price$0.7651
Volume39.72K
Volume39.72K
52 Week high$11.91
52 Week high$11.91
52 Week low$0.6516
52 Week low$0.6516